Keylicon Biosciences Secures Exclusive Rights to Modified Self-Amplifying RNA Technology
Hand-out
Press Releases

Keylicon Biosciences Secures Exclusive Rights to Modified Self-Amplifying RNA Technology

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Keylicon Biosciences is pleased to announce its exclusive rights to a groundbreaking next-generation RNA technology developed at Boston University. This innovation enables protein expression

avatar profile Olean Times Herald

Olean Times Herald


Local & Social